Redeye updates its estimates and valuation following the Q1 2025 report from Safeture.
Redeye is only making some minor adjustments to our forecasts and valuation on the back of Q1 number...
Higher costs partially offset by lower net financials in Q1 Outgrowing the sector on cash earnings i...
Redeye retains its positive view of Vertiseit following a Q1 report where FX and a higher headcount ...
Cost initiatives a success in FWMT... ...and Scandpower continues to excel High competition and pric...
Strong SATCOM sales, but surprising setback in terminal sales '25e-'26e sales down 8-9% on FX headwi...
Q1 NAV -1% vs. ABGSCe Safe Life continues to deliver solid growth Fair value range lowered to SEK 23...
Redeye updates its estimates ahead of Arise’s Q1 report, which is due on 29 April.
Redeye shares its preview for RaySearch’s Q1 2025 report, due May 9.
Redeye comments on Alligator's first quarter 2025, during which a rights issue of gross SEK150m was ...
Redeye provides its initial take on Heliospectra’s Q1 results, noting that while sales were below ex...
Sales -1% and adj. EBIT -18% vs. ABGSCe Operating cash flow significantly better than expected Likel...
Dynavox delivered a robust Q1, with sales coming in 16% above our forecast and 13% ahead of consensu...
Sales -7% vs. ABGSCe at SEK 32m EBITDA better than expected (SEK -0.
